Architecture and self-assembly of theSARS-CoV-2 nucleocapsid protein

被引:7
|
作者
Ye, Qiaozhen [1 ]
West, Alan M. V. [1 ]
Silletti, Steve [2 ]
Corbett, Kevin D. [1 ,2 ,3 ]
机构
[1] Univ Calif San Diego, Dept Cellular & Mol Med, 9500 Gilman Dr,3206, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA
[3] Ludwig Inst Canc Res, La Jolla, CA USA
基金
美国国家卫生研究院;
关键词
coronavirus; COVID-19; crystal structure; nucleocapsid; SARS-CoV-2; C-TERMINAL DOMAINS; SARS CORONAVIRUS; DIMERIZATION DOMAIN; CRYSTAL-STRUCTURE; VIRUS; RIBONUCLEOPROTEIN; IDENTIFICATION; ASSOCIATION; MECHANISM; GS-5734;
D O I
10.1002/pro.3909
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The COVID-2019 pandemic is the most severe acute public health threat of the twenty-first century. To properly address this crisis with both robust testing and novel treatments, we require a deep understanding of the life cycle of the causative agent, the SARS-CoV-2 coronavirus. Here, we examine the architecture and self-assembly properties of the SARS-CoV-2 nucleocapsid protein, which packages viral RNA into new virions. We determined a 1.4 angstrom resolution crystal structure of this protein's N2b domain, revealing a compact, intertwined dimer similar to that of related coronaviruses including SARS-CoV. While the N2b domain forms a dimer in solution, addition of the C-terminal spacer B/N3 domain mediates formation of a homotetramer. Using hydrogen-deuterium exchange mass spectrometry, we find evidence that at least part of this putatively disordered domain is structured, potentially forming an alpha-helix that self-associates and cooperates with the N2b domain to mediate tetramer formation. Finally, we map the locations of amino acid substitutions in the N protein from over 38,000 SARS-CoV-2 genome sequences. We find that these substitutions are strongly clustered in the protein's N2a linker domain, and that substitutions within the N1b and N2b domains cluster away from their functional RNA binding and dimerization interfaces. Overall, this work reveals the architecture and self-assembly properties of a key protein in the SARS-CoV-2 life cycle, with implications for both drug design and antibody-based testing.
引用
收藏
页码:1890 / 1901
页数:12
相关论文
共 50 条
  • [1] Modular characterization of SARS-CoV-2 nucleocapsid protein domain functions in nucleocapsid-like assembly
    Wang, Yan
    Ling, Xiaobin
    Zhang, Chong
    Zou, Jian
    Luo, Bingnan
    Luo, Yongbo
    Jia, Xinyu
    Jia, Guowen
    Zhang, Minghua
    Hu, Junchao
    Liu, Ting
    Wang, Yuanfeiyi
    Lu, Kefeng
    Li, Dan
    Ma, Jinbiao
    Liu, Cong
    Su, Zhaoming
    MOLECULAR BIOMEDICINE, 2023, 4 (01):
  • [2] SARS-CoV-2 Nucleocapsid Protein Is a Potential Therapeutic Target for Anticoronavirus Drug Discovery
    Royster, Austin
    Ren, Songyang
    Ma, Yutian
    Pintado, Melissa
    Kahng, Eunice
    Rowan, Sean
    Mir, Sheema
    Mir, Mohammad
    MICROBIOLOGY SPECTRUM, 2023, 11 (03):
  • [3] Overview of the SARS-CoV-2 nucleocapsid protein
    Eltayeb, Ahmed
    Al-Sarraj, Faisal
    Alharbi, Mona
    Albiheyri, Raed
    Mattar, Ehab
    Zeid, Isam M. Abu
    Bouback, Thamer A.
    Bamagoos, Atif
    Aljohny, Bassam O.
    Uversky, Vladimir N.
    Redwan, Elrashdy M.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 260
  • [4] Blood use and transfusion needs at a large health care system in Washington state during theSARS-CoV-2 pandemic
    Pagano, Monica B.
    Cataife, Guido
    Fertrin, Kleber Yotsumoto
    Gernsheimer, Terry
    Hess, John R.
    Staley, Elizabeth
    Clark, Christine
    Senn, Nina
    Tuott, Erin
    Tsang, Hamilton C.
    TRANSFUSION, 2020, 60 (12) : 2859 - 2866
  • [5] Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites
    Kang, Sisi
    Yang, Mei
    Hong, Zhongsi
    Zhang, Liping
    Huang, Zhaoxia
    Chen, Xiaoxue
    He, Suhua
    Zhou, Ziliang
    Zhou, Zhechong
    Chen, Qiuyue
    Yan, Yan
    Zhang, Changsheng
    Shan, Hong
    Chen, Shoudeng
    ACTA PHARMACEUTICA SINICA B, 2020, 10 (07) : 1228 - 1238
  • [6] Assembly of SARS-CoV-2 ribonucleosomes by truncated N* variant of the nucleocapsid protein
    Adly, Armin N.
    Bi, Maxine
    Carlson, Christopher R.
    Syed, Abdullah M.
    Ciling, Alison
    Doudna, Jennifer A.
    Cheng, Yifan
    Morgan, David O.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2023, 299 (12)
  • [7] Characterization of SARS-CoV-2 nucleocapsid protein oligomers
    Farci, Domenica
    Graca, Andre T.
    Hall, Michael
    Haniewicz, Patrycja
    Kereiche, Sami
    Faull, Peter
    Kirkpatrick, Joanna
    Tramontano, Enzo
    Schroder, Wolfgang P.
    Piano, Dario
    JOURNAL OF STRUCTURAL BIOLOGY, 2025, 217 (01)
  • [8] Structural Insight Into the SARS-CoV-2 Nucleocapsid Protein C-Terminal Domain Reveals a Novel Recognition Mechanism for Viral Transcriptional Regulatory Sequences
    Yang, Mei
    He, Suhua
    Chen, Xiaoxue
    Huang, Zhaoxia
    Zhou, Ziliang
    Zhou, Zhechong
    Chen, Qiuyue
    Chen, Shoudeng
    Kang, Sisi
    FRONTIERS IN CHEMISTRY, 2021, 8
  • [9] Structural characterization of the C-terminal domain of SARS-CoV-2 nucleocapsid protein
    Zhou, Renjie
    Zeng, Rui
    von Brunn, Albrecht
    Lei, Jian
    MOLECULAR BIOMEDICINE, 2020, 1 (01):
  • [10] Production and Characterization of a SARS-CoV-2 Nucleocapsid Protein Reference Material
    Stocks, Bradley B.
    Thibeault, Marie-Pier
    L'Abbe, Denis
    Stuible, Matthew
    Durocher, Yves
    Melanson, Jeremy E.
    ACS MEASUREMENT SCIENCE AU, 2022, 2 (06): : 620 - 628